The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
A gene complex controlling segmentation in Drosophila
Lewis, E. B. (1978) · Nature · doi:10.1038/276565a0 · Cited by 3,812
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,523
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,514
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K.-I., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,268
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
A Chromatin Landmark and Transcription Initiation at Most Promoters in Human Cells
Guenther, M. G., Levine, S. S., Boyer, L. A., Jaenisch, R., & Young, R. A. (2007) · Cell · doi:10.1016/j.cell.2007.05.042 · Cited by 1,944
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A., Wild, B., Miller, E. L., O'Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,562
Self-citationCzermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,533
UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development
Agger, K., Cloos, P. A. C., Christensen, J., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., Canaani, E., Salcini, A. E., & Helin, K. (2007) · Nature · doi:10.1038/nature06145 · Cited by 1,388
Polycomb silencers control cell fate, development and cancer
Sparmann, A., & van Lohuizen, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1991 · Cited by 1,303
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., & Helin, K. (2006) · Genes & Development · doi:10.1101/gad.381706 · Cited by 1,257
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Global histone modification patterns predict risk of prostate cancer recurrence
Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., & Kurdistani, S. K. (2005) · Nature · doi:10.1038/nature03672 · Cited by 1,092
The Biology of Cancer Stem Cells
Lobo, N. A., Shimono, Y., Qian, D., & Clarke, M. F. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104154 · Cited by 1,043
Fischle, W., Wang, Y., Jacobs, S. A., Kim, Y., Allis, C. D., & Khorasanizadeh, S. (2003) · Genes & Development · doi:10.1101/gad.1110503 · Cited by 991
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity
Pasini, D., Bracken, A. P., Jensen, M. R., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600402 · Cited by 916
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
Cao, R., & Zhang, Y. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.02.001 · Cited by 914
The Polycomb-Group Gene Ezh2 Is Required for Early Mouse Development
O'Carroll, D., Erhardt, S., Pagani, M., Barton, S. C., Surani, M. A., & Jenuwein, T. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4330-4336.2001 · Cited by 912
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Polycomb silencing mechanisms and the management of genomic programmes
Schwartz, Y. B., & Pirrotta, V. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1981 · Cited by 868
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
Role of Bmi-1 and Ring1A in H2A Ubiquitylation and Hox Gene Silencing
Cao, R., Tsukada, Y.-I., & Zhang, Y. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.12.002 · Cited by 857
Bachmann, I. M., Halvorsen, O. J., Collett, K., Stefansson, I. M., Straume, O., Haukaas, S. A., Salvesen, H. B., Otte, A. P., & Akslen, L. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5180 · Cited by 851
The SET-domain protein superfamily: protein lysine methyltransferases.
Dillon, S. C., Zhang, X. Y., Trievel, R. C., & Cheng, X. (2005) · Genome biology · doi:10.1186/gb-2005-6-8-227 · Cited by 843
Chromatin Compaction by a Polycomb Group Protein Complex
Francis, N. J., Kingston, R. E., & Woodcock, C. L. (2004) · Science · doi:10.1126/science.1100576 · Cited by 840
Cao, R., & Zhang, Y. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.020 · Cited by 812
RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo
Zeitlinger, J., Stark, A., Kellis, M., Hong, J.-W., Nechaev, S., Adelman, K., Levine, M., & Young, R. A. (2007) · Nature Genetics · doi:10.1038/ng.2007.26 · Cited by 765
The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell Differentiation
Pasini, D., Bracken, A. P., Hansen, J. B., Capillo, M., & Helin, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01432-06 · Cited by 696
Stock, J. K., Giadrossi, S., Casanova, M., Brookes, E., Vidal, M., Koseki, H., Brockdorff, N., Fisher, A. G., & Pombo, A. (2007) · Nature Cell Biology · doi:10.1038/ncb1663 · Cited by 650
Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement
Su, I.-H., Basavaraj, A., Krutchinsky, A. N., Hobert, O., Ullrich, A., Chait, B. T., & Tarakhovsky, A. (2003) · Nature Immunology · doi:10.1038/ni876 · Cited by 611
Genome-wide analysis of Polycomb targets in Drosophila melanogaster
Schwartz, Y. B., Kahn, T. G., Nix, D. A., Li, X.-Y., Bourgon, R., Biggin, M., & Pirrotta, V. (2006) · Nature Genetics · doi:10.1038/ng1817 · Cited by 610
Caretti, G., Di Padova, M., Micales, B., Lyons, G. E., & Sartorelli, V. (2004) · Genes & Development · doi:10.1101/gad.1241904 · Cited by 600
Hierarchical Recruitment of Polycomb Group Silencing Complexes
Wang, L., Brown, J. L., Cao, R., Zhang, Y., Kassis, J. A., & Jones, R. S. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.05.009 · Cited by 561
Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3
Cha, T.-L., Zhou, B. P., Xia, W., Wu, Y., Yang, C.-C., Chen, C.-T., Ping, B., Otte, A. P., & Hung, M.-C. (2005) · Science · doi:10.1126/science.1118947 · Cited by 548
van der Vlag, J., & Otte, A. P. (1999) · Nature Genetics · doi:10.1038/70602 · Cited by 527
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
Lyko, F., & Brown, R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji311 · Cited by 510
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27
Kirmizis, A., Bartley, S. M., Kuzmichev, A., Margueron, R., Reinberg, D., Green, R., & Farnham, P. J. (2004) · Genes & Development · doi:10.1101/gad.1200204 · Cited by 495
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
Drummond, D. C., Noble, C. O., Kirpotin, D. B., Guo, Z., Scott, G. K., & Benz, C. C. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095825 · Cited by 494
Gore, S. D., Baylin, S., Sugar, E., Carraway, H., Miller, C. B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J. E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0080 · Cited by 474
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
Stingl, J., & Caldas, C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2212 · Cited by 470
Different Ezh2-Containing Complexes Target Methylation of Histone H1 or Nucleosomal Histone H3
Kuzmichev, A., Jenuwein, T., Tempst, P., & Reinberg, D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00185-6 · Cited by 449
The cancer epigenome—components and functional correlates
Ting, A. H., McGarvey, K. M., & Baylin, S. B. (2006) · Genes & Development · doi:10.1101/gad.1464906 · Cited by 419
SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron
Jepsen, K., Solum, D., Zhou, T., McEvilly, R. J., Kim, H.-J., Glass, C. K., Hermanson, O., & Rosenfeld, M. G. (2007) · Nature · doi:10.1038/nature06270 · Cited by 399
Levine, S. S., Weiss, A., Erdjument-Bromage, H., Shao, Z., Tempst, P., & Kingston, R. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6070-6078.2002 · Cited by 388
Genome-wide profiling of PRC1 and PRC2 Polycomb chromatin binding in Drosophila melanogaster
Tolhuis, B., Muijrers, I., de Wit, E., Teunissen, H., Talhout, W., van Steensel, B., & van Lohuizen, M. (2006) · Nature Genetics · doi:10.1038/ng1792 · Cited by 381
A gene product required for correct initiation of segmental determination in Drosophila
Struhl, G. (1981) · Nature · doi:10.1038/293036a0 · Cited by 366
Polycomb Group Protein Ezh2 Controls Actin Polymerization and Cell Signaling
Su, I.-H., Dobenecker, M.-W., Dickinson, E., Oser, M., Basavaraj, A., Marqueron, R., Viale, A., Reinberg, D., Wülfing, C., & Tarakhovsky, A. (2005) · Cell · doi:10.1016/j.cell.2005.02.029 · Cited by 365
A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome
Yu, J., Yu, J., Rhodes, D. R., Tomlins, S. A., Cao, X., Chen, G., Mehra, R., Wang, X., Ghosh, D., Shah, R. B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2498 · Cited by 348
The Murine Polycomb Group Protein Eed Is Required for Global Histone H3 Lysine-27 Methylation
Montgomery, N. D., Yee, D., Chen, A., Kalantry, S., Chamberlain, S. J., Otte, A. P., & Magnuson, T. (2005) · Current Biology · doi:10.1016/j.cub.2005.04.051 · Cited by 345
Shi, B., Liang, J., Yang, X., Wang, Y., Zhao, Y., Wu, H., Sun, L., Zhang, Y., Chen, Y., Li, R., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00162-07 · Cited by 340
Kuzmichev, A., Margueron, R., Vaquero, A., Preissner, T. S., Scher, M., Kirmizis, A., Ouyang, X., Brockdorff, N., Abate-Shen, C., Farnham, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409875102 · Cited by 336
Erhardt, S., Su, I.-H., Schneider, R., Barton, S., Bannister, A. J., Perez-Burgos, L., Jenuwein, T., Kouzarides, T., Tarakhovsky, A., & Surani, M. A. (2003) · Development · doi:10.1242/dev.00625 · Cited by 324
Suz12 binds to silenced regions of the genome in a cell-type-specific manner
Squazzo, S. L., O’Geen, H., Komashko, V. M., Krig, S. R., Jin, V. X., Jang, S.-W., Margueron, R., Reinberg, D., Green, R., & Farnham, P. J. (2006) · Genome Research · doi:10.1101/gr.5306606 · Cited by 316
Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies
Bhalla, K. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.600 · Cited by 308
Wei, Y., Xia, W., Zhang, Z., Liu, J., Wang, H., Adsay, N. V., Albarracin, C., Yu, D., Abbruzzese, J. L., Mills, G. B., et al. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20413 · Cited by 305
Endoh, M., Endo, T. A., Endoh, T., Fujimura, Y.-I., Ohara, O., Toyoda, T., Otte, A. P., Okano, M., Brockdorff, N., Vidal, M., et al. (2008) · Development · doi:10.1242/dev.014340 · Cited by 290
Ezh2 Requires PHF1 To Efficiently Catalyze H3 Lysine 27 Trimethylation In Vivo
Sarma, K., Margueron, R., Ivanov, A., Pirrotta, V., & Reinberg, D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02017-07 · Cited by 286
Laible, G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3219 · Cited by 280
Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes
Nekrasov, M., Klymenko, T., Fraterman, S., Papp, B., Oktaba, K., Köcher, T., Cohen, A., Stunnenberg, H. G., Wilm, M., & Müller, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601837 · Cited by 280
Collett, K., Eide, G. E., Arnes, J., Stefansson, I. M., Eide, J., Braaten, A., Aas, T., Otte, A. P., & Akslen, L. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1533 · Cited by 272
Rhodes, D. R., Sanda, M. G., Otte, A. P., Chinnaiyan, A. M., & Rubin, M. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.661 · Cited by 271
Tie, F., Furuyama, T., Prasad-Sinha, J., Jane, E., & J. Harte, P. (2001) · Development · doi:10.1242/dev.128.2.275 · Cited by 271
van Kemenade, F. J., Raaphorst, F. M., Blokzijl, T., Fieret, E., Hamer, K. M., Satijn, D. P. E., Otte, A. P., & Meijer, C. J. L. M. (2001) · Blood · doi:10.1182/blood.v97.12.3896 · Cited by 266
Polycomb response elements and targeting of Polycomb group proteins in Drosophila
Müller, J., & Kassis, J. A. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.08.005 · Cited by 262
Chromosomal Distribution of PcG Proteins during Drosophila Development
Nègre, N., Hennetin, J., Sun, L. V., Lavrov, S., Bellis, M., White, K. P., & Cavalli, G. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040170 · Cited by 247
Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia
Villa, R., Pasini, D., Gutierrez, A., Morey, L., Occhionorelli, M., Viré, E., Nomdedeu, J. F., Jenuwein, T., Pelicci, P. G., Minucci, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.009 · Cited by 247
Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma
Sudo, T., Utsunomiya, T., Mimori, K., Nagahara, H., Ogawa, K., Inoue, H., Wakiyama, S., Fujita, H., Shirouzu, K., & Mori, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602531 · Cited by 243
The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
Visser, H. P. J., Gunster, M. J., Kluin‐Nelemans, H. C., Manders, E. M. M., Raaphorst, F. M., Meijer, C. J. L. M., Willemze, R., & Otte, A. P. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02641.x · Cited by 234
Jones, R. S., & Gelbart, W. M. (1990) · Genetics · doi:10.1093/genetics/126.1.185 · Cited by 225
Ketel, C. S., Andersen, E. F., Vargas, M. L., Suh, J., Strome, S., & Simon, J. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.6857-6868.2005 · Cited by 216
Self-citationMatsukawa, Y., Semba, S., Kato, H., Ito, A., Yanagihara, K., & Yokozaki, H. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00203.x · Cited by 212
Polycomb group and trithorax group proteins in Arabidopsis
Pien, S., & Grossniklaus, U. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2007.01.010 · Cited by 202
Heard, E. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.08.009 · Cited by 197
Raaphorst, F. M., Meijer, C. J. L. M., Fieret, E., Blokzijl, T., Mommers, E., Buerger, H., Packeisen, J., Sewalt, R. A. B., Ottet, A. P., & van Diest, P. J. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80032-5 · Cited by 194
Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder
Raman, J. D., Mongan, N. P., Tickoo, S. K., Boorjian, S. A., Scherr, D. S., & Gudas, L. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1047 · Cited by 193
The MES-2/MES-3/MES-6 Complex and Regulation of Histone H3 Methylation in C. elegans
Bender, L. B., Cao, R., Zhang, Y., & Strome, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.08.062 · Cited by 189
van Leenders, G. J. L. H., Dukers, D., Hessels, D., van den Kieboom, S. W. M., Hulsbergen, C. A., Witjes, J. A., Otte, A. P., Meijer, C. J., & Raaphorst, F. M. (2007) · European Urology · doi:10.1016/j.eururo.2006.11.020 · Cited by 181
Nucleosome binding and histone methyltransferase activity of Drosophila PRC2
Nekrasov, M., Wild, B., & Müller, J. (2005) · EMBO reports · doi:10.1038/sj.embor.7400376 · Cited by 177
Role of hPHF1 in H3K27 Methylation and Hox Gene Silencing
Cao, R., Wang, H., He, J., Erdjument-Bromage, H., Tempst, P., & Zhang, Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01589-07 · Cited by 173
Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s Disease
Raaphorst, F. M., van Kemenade, F. J., Blokzijl, T., Fieret, E., Hamer, K. M., Satijn, D. P. E., Otte, A. P., & Meijer, C. J. L. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64583-x · Cited by 166
Croonquist, P. A., & Van Ness, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208771 · Cited by 162
Structural Basis of EZH2 Recognition by EED
Han, Z., Xing, X., Hu, M., Zhang, Y., Liu, P., & Chai, J. (2007) · Structure · doi:10.1016/j.str.2007.08.007 · Cited by 162
EZH2 promotes proliferation and invasiveness of prostate cancer cells
Bryant, R. J., Cross, N. A., Eaton, C. L., Hamdy, F. C., & Cunliffe, V. T. (2007) · The Prostate · doi:10.1002/pros.20550 · Cited by 159
Berezovska, O. P., Glinskii, A. B., Yang, Z., Li, X., Hoffman, R. M., & Glinsky, G. V. (2006) · Cell Cycle · doi:10.4161/cc.5.16.3222 · Cited by 159
Weikert, S., Christoph, F., Köllermann, J. W., Müller, M., Schrader, M. G., Miller, K., & Krause, H. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.16.2.349 · Cited by 151
The Polycomb group — no longer an exclusive club?
Brock, H. W., & van Lohuizen, M. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00176-3 · Cited by 150
Saramäki, O. R., Tammela, T. L. J., MARTIKAINEN, P. M., Vessella, R. L., & Visakorpi, T. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20327 · Cited by 146
Kirmizis, A., Bartley, S. M., & Farnham, P. (2003) · PubMed · Cited by 141
Ding, L., Erdmann, C. A., Chinnaiyan, A. M., Merajver, S. D., & Kleer, C. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4300 · Cited by 132
Connections between epigenetic gene silencing and human disease
Moss, T. J. M., & Wallrath, L. L. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.05.038 · Cited by 128
McGarvey, K. M., Greene, E., Fahrner, J. A., Jenuwein, T., & Baylin, S. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2029 · Cited by 127
van der Stoop, P. P. M., Boutsma, E., Hulsman, D., Noback, S., Heimerikx, M., Kerkhoven, R. M., Voncken, J. W., Wessels, L. F. A., & van Lohuizen, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002235 · Cited by 121
Breuer, R. H. J., Snijders, P. J. F., Smit, E. F., Sutedja, T. G., Sewalt, R. G. A. B., Otte, A. P., van Kemenade, F. J., Postmus, P. E., Meijer, C. J. L. M., & Raaphorst, F. M. (2004) · Neoplasia · doi:10.1593/neo.04160 · Cited by 120
Substrate Preferences of the EZH2 Histone Methyltransferase Complex
Martin, C., Cao, R., & Zhang, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513425200 · Cited by 107
E(z): a polycomb group gene or a trithorax group gene?
LaJeunesse, D., & Shearn, A. (1996) · Development · doi:10.1242/dev.122.7.2189 · Cited by 101
Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma
Arısan, S., Arısan, E. D., Palavan-Ünsal, N., Çaşkurlu, T., Çakır, Ö. O., & Ergenekon, E. (2005) · Urologia Internationalis · doi:10.1159/000087804 · Cited by 99
A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers
Wang, S., Robertson, G. P., & Zhu, J. (2004) · Gene · doi:10.1016/j.gene.2004.09.006 · Cited by 99
Expression of polycomb group protein EZH2 in nevi and melanoma
McHugh, J. B., Fullen, D. R., Ma, L., Kleer, C. G., & Su, L. D. (2006) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2006.00678.x · Cited by 89
Effects of rearrangement and allelic exclusion of JJAZ1 / SUZ12 on cell proliferation and survival
Li, H., Ma, X., Wang, J., Koontz, J. I., Nucci, M. R., & Sklar, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709986104 · Cited by 86
Savla, U., Benes, J. J., Zhang, J., & Jones, R. S. (2008) · Development · doi:10.1242/dev.016006 · Cited by 81
Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases
Mimori, K., Ogawa, K., Okamoto, M., Sudo, T., Inoue, H., & Mori, M. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.11.001 · Cited by 73
Structural dynamics of protein lysine methylation and demethylation
Cheng, X., & Zhang, X. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.05.041 · Cited by 73
Isolation and developmental expression analysis of Enx-1, a novel mouse Polycomb group gene
Hobert, O., Sures, I., Ciossek, T., Fuchs, M., & Ullrich, A. (1996) · Mechanisms of Development · doi:10.1016/0925-4773(96)00499-6 · Cited by 71
The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells
Bryant, R. J., Winder, S. J., Cross, S. S., Hamdy, F. C., & Cunliffe, V. T. (2007) · The Prostate · doi:10.1002/pros.20705 · Cited by 47
Cited by
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
Kulis, M., & Esteller, M. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60002-2 · Cited by 1,566
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D. (2013) · Science · doi:10.1126/science.1232245 · Cited by 1,345
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Mechanisms of Polycomb gene silencing: knowns and unknowns
Simon, J. A., & Kingston, R. E. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2763 · Cited by 1,317
Self-citation
Metadata
- Authors
- Simon, J. A., & Lange, C. A.
- Venue
- Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 647
- Issue
- 1-2
- Pages
- 21-29
- ISSN
- 0027-5107 (ISSN-L)
- 1386-1964
- OpenAlex
- W2100543217
- Cited by
- 855
- References
- 128
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.